PRIVATE EQUITY: FRIEND OR FOE TO HEALTHCARE?
Finance executives evaluate the role of private equity in the healthcare industry and forecast how the dynamic will evolve. When private equity firms invest in healthcare, who benefits?
CLOVER HEALTH PRESIDENT DISCUSSES RECENT IPO, MA GROWTH PLANS
Last Friday, Clover had its SPAC IPO on the Nasdaq, opening with a stock price of $15.30.
COURT OVERRULES PROVIDENCE'S OBJECTIONS TO HOAG'S AFFILIATION LAWSUIT
In a statement, Hoag stated that it welcomes the decision issued Tuesday.
THE HUGE OPPORTUNITY TO USE TECHNOLOGY TO BRING 'GREAT HEALTHCARE TO MORE PEOPLE': INTERVIEW WITH CLOVER HEALTH'S ANDREW TOY
The visionary executive of a technology-oriented Medicare Advantage company outlines the future in this sector and the importance of being a leader of Asian descent in healthcare.
BCBS MN CEO: RETHINKING THE ROLE OF THE PAYER
Craig Samitt, MD, MBA analyzes the turbulence of 2020, the lingering challenges facing healthcare, and what opportunities are available for forward-thinking executives in 2021.
HOUSE DELAYS MEDICARE 2% SEQUESTER CUTS THROUGH 2021
President Biden is expected to sign the bill, which has already cleared the Senate.
BABYLON CHIEF BUSINESS OFFICER ON PUSHING THE U.S. TOWARDS VALUE-BASED CARE
Paul-Henri Ferrand, Chief Business Officer of Babylon, discusses the U.K.-based healthcare company's goals to promote value-based care in the U.S.
ONE-YEAR RETROSPECTIVE ON COVID-19: LOOKING BACK, LOOKING AHEAD
Healthcare executives reflect on the strategic, innovative, and clinical opportunities hospitals have realized during the pandemic and contemplate the future.
2022 OPPS PROPOSED RULE: CMS BACKING OFF FROM ELIMINATING INPATIENT-ONLY LIST, INCREASING PRICE TRANSPARENCY PENALTIES
In addition, CMS says it intends to increase hospital compliance with its price transparency policies by increasing financial penalties for certain facilities.